Total Funding
57
39
Total FundingDebt Financing raised
Growth Score
-5 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
125224
Tetragenetics helps people seeking a cost-effective alternative platform technology for the production of genetically engineered proteins.
R. Douglas Kahn: Chairman & CEOPast Role: PanAmSat, President & CEO
Doug Kahn: Chairman & CEOPast Role: Thermo Fisher Scientific, VP & General Manager
About the Company
Tetragenetics is an early-stage biotechnology company meeting the needs of customers who seek a cost-effective alternative platform technology for the production of genetically engineered proteins. Their technology is particularly well suited to the production of eucaryotic membrane and secretory proteins that are difficult to express in
conventional systems. Such proteins include vaccine antigens, monoclonal antibodies, and a variety of therapeutic proteins for the treatment and prevention of human and animal disease.
